Grilled Cheese

ExploreLog inSign up
Terms of UsePrivacy PolicyCommunity StandardsHelpGet the app

Grilled Cheese is a product of Village Compute

Version devBuilt at: 2026-10-15 19:58:26 EDT

PhotosVideosAllPeople
LatestRanked
@aasldnews.bsky.socialOct 15, 2026, 5:18 PM

Keep your education on-the-go with our Oct. 27 webinar discussing newly proposed definitions of #obesity and the genetic and metabolic factors in the pathogenesis of lean #MASLD. Hear from the experts on this timely discussion and register today https://bit.ly/3W5SXeQ.

#METALD #ALD

Photo, no description
@gastroadvisor.bsky.socialOct 15, 2026, 3:04 PM

Sleep quality, but not sleep duration, is independently associated with metabolic dysfunction-associated steatotic liver disease (#MASLD) in adults #ACG2026

Read more: https://www.gastroenterologyadvisor.com/reports/sleep-disturbance-metabolic-associated-steatotic-liver-disease/

@liversmdpi.bsky.socialOct 15, 2026, 3:29 AM

📢 New Article in #LiversMDPI

🧬 Chamarthi et al. compared AFP, PIVKA-II, and the ASAP score for HCC diagnosis in 1305 participants.

🩺 ASAP showed the best overall diagnostic performance across multiple HCC subgroups.

📖 Read More: www.mdpi.com/2673-4389/6/...

#HCC #AFP #PIVKAII #MASLD

Photo, no description
@aasldnews.bsky.socialOct 14, 2026, 1:45 PM

🔥 HOT TOPIC

Nearly 1 in 5 youth with biopsy-confirmed #MASLD began drinking during adolescence or early adulthood.

Read the article: https://bit.ly/4rPDaN0

Photo, no description
@liversmdpi.bsky.socialOct 14, 2026, 1:27 AM

📢 New Review in #LiversMDPI

🧬 Colella et al. review gut microbiota changes in NAFLD/MASLD.

🩺 No consistent microbial signature was reproduced across populations, disease stages, and platforms.

📖 Read More: www.mdpi.com/2673-4389/6/...

#NAFLD #MASLD #GutMicrobiota #fibrosis

Photo, no description
@asipath.bsky.socialOct 13, 2026, 1:04 PM

There is still time to register for this #SLAMCommunity #VirtualEvent! Register here https://bit.ly/3V6iIet

#SLAM #LiverResearch #MASLD #ALD #Hepatology @harvardmed.bsky.social

Photo, no description
@aasldnews.bsky.socialOct 12, 2026, 9:31 PM

🔥 HOT TOPIC

For patients with #MASLD and elevated FIB-4, which elastography method works best for the next step?

Read the article: https://bit.ly/4yARD1R

Photo, no description
@perspectumltd.bsky.socialOct 12, 2026, 9:59 AM

Alone, cT1, liver fat and spleen volume identified cirrhosis in MASLD with AUC 0.66 to 0.72. Combined: 0.87 (test cohort 0.85). Michele Pansini presents this poster at the Society for Advanced Body Imaging 2026, 13th October. Find him there or at our tabletop. #Perspectum #MASLD

Photo, no description
@mirkozoncape.bsky.socialOct 10, 2026, 3:36 PM

Wrapping up Module 2 of the #EASL #MASLD Guidelines Academy in Antwerp 🇧🇪
Two inspiring days of science, discussion and knowledge sharing with leading experts and colleagues from around the world 🌎
A great experience, full of new insights and valuable connections!

Photo, no description
@healthday.bsky.socialOct 9, 2026, 6:41 PM

A new study finds people who eat after dinner or after bedtime have a significantly higher risk for fatty liver disease and cirrhosis.
youtu.be/1AWoHiGpzfU

#fattyliver #liverhealth #masld #liverdisease #livercirrhosis #cirrhosis #latenighteating #nighttimeeating #eatingbeforebed #eatbeforesleep

@mirkozoncape.bsky.socialOct 9, 2026, 7:21 AM

Day 1 of Module 2 of the #EASL MASLD Guidelines Academy in
#Antwerp! 🇧🇪
A deeper dive into #MASLD, with inspiring talks, stimulating discussions and great colleagues from 🌎 all over the world.
Always a pleasure to learn, share ideas and exchange experiences with experts in the field! 📚🔬

Photo, no description
@diabetologiajnl.bsky.socialOct 8, 2026, 4:24 PM

New study shows empagliflozin and dapagliflozin have comparable risk of liver-related complications, with only marginally greater improvement in fatty liver with empagliflozin, in adults with type 2 diabetes and MASLD. #MASLD #SGLT2i #T2D #LiverHealth link.springer.com/article/10.1...

@tumorscholar.bsky.socialOct 8, 2026, 8:28 AM

Ulcerative colitis remission leaves persistent LCN2+ macrophages with heightened glycolysis and H3K9la memory.

#MASLD #GutLiverAxis #LiverSky #Hepatology
https://doi.org/10.1016/j.cmet.2026.09.008

@thelancetendo.bsky.socialOct 7, 2026, 7:06 AM

In @eclinicalmed.bsky.social

Dose-dependent efficacy & renal safety of pemafibrate versus fenofibrate in patients with metabolic dysfunction-associated steatotic liver disease (#MASLD) & hypertriglyceridemia: a multicenter randomized controlled, open label trial www.thelancet.com/journals/ecl....

@childrensresearch.bsky.socialOct 6, 2026, 8:53 PM

Can bariatric surgery reduce the risk of fatty liver disease, or #MASLD, and what role can GLP-1s play in the treatment of severe obesity and related medical conditions? #BariatricSurgery

@jama.comOct 6, 2026, 1:00 PM

Among patients with #MASLD, although lean patients had fewer metabolic comorbidities and less severe histologic disease mortality and clinical events did not differ significantly from patients with overweight or #obesity.

#liver #BMI

📌 Learn more: ja.ma/4ysP4ik

@isev.orgOct 6, 2026, 12:55 PM

📘Read in #JExBio📘 Extracellular Vesicle-Based miRNA Profiling in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Secondary Analysis of the MULTISITE Clinical Trial #extracellularvesicles #biomarkers #MASLD #NAFLD isevjournals.onlinelibrary.wiley.com/doi/epdf/10....

Photo, no description
@rcatanho.bsky.socialOct 6, 2026, 6:08 AM

Hepatopatía esteatósica asoc a disf metab magra fenotipo c enf histológica más leve y variables clínicas similares a asoc a sobrepeso/obesidad, gravedad de fibrosis asoc c/pronóstico, medición de rigidez hepática es confiable en magros #MASLD #lean jamanetwork.com/journals/jam...

@aging-us.bsky.socialOct 4, 2026, 6:00 PM

🎥 #AgingShort:
"Adipo-neuroinflammation, cognitive impairment and surrogate markers of cardiovascular risk in patients with Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD)”

🔗 https://bit.ly/4wjuAaT

#Aging #TrendingWithImpact #MASLD #BrainHealth #CardiovascularHealth #LiverDisease

@aging-us.bsky.socialOct 4, 2026, 4:00 PM

📈 #TrendingWithImpact:
"Adipo-neuroinflammation, cognitive impairment and surrogate markers of cardiovascular risk in patients with Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD)"

#PressRelease ⬇️
https://bit.ly/4xjU6wL

#Aging #Research #MASLD #OA #Press

Load more